跳至主要内容
临床试验/JPRN-UMIN000040163
JPRN-UMIN000040163已完成未知

Study for the pathogenesis of eosinophilic polyangiitis granulomatosis (EGPA) - Study for the pathogenesis of eosinophilic polyangiitis granulomatosis (EGPA)

ational Hospital Organization Sagamihara National Hospital0 个研究点目标入组 100 人开始时间: 2020年4月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

In active EGPA, 33 proteins, mainly related to eosinophils, type 2 inflammation, and cell adhesion factors, were elevated compared to asthma. In contrast, 12 proteins were decreased with steroid treatment. Fifty-nine proteins, including functional proteins involved in cell proliferation, angiogenesis, and type 3 inflammation as well as eosinophilic inflammation, were altered by the additional administration of mepolizumab. MicroRNA coverage analysis showed 8 significantly different between EGPA and asthma.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Individuals who are judged to be ineligible by the study representative or the treating physician

研究者

发起方
ational Hospital Organization Sagamihara National Hospital

相似试验